Information for Healthcare Professionals - Chondrolysis Reported with Continuously Infused Local Anesthetics (marketed as bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine and ropivacaine)
Links shared publicly online about this topic.
- 1,601total visits
Information for Healthcare Professionals - Chondrolysis Reported with Continuously Infused Local Anesthetics (marketed as bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine and ropivacaine)
i.cx —
The Food and Drug Administration (FDA) has reviewed 35 reports of chondrolysis (necrosis and destruction of cartilage) in patients given continuous intra-articular infusions of local anesthetics with elastomeric infusion devices to control post-surgical pain.
View full resource at i.cx
Tags: Pain, Drug, Healthcare, FDA, Lidoderm
Most Recently Shared on November 15, 2009 at 11:50 am By:
RT @EllenRichter FDA: Chondrolysis (destruction of cartiledge) reprtd w/ continuous infusion, local anesthetics http://bit.ly/2zhUFC #pain
Advertisement
